loading
22nd Century Group, Inc. stock is traded at $1.31, with a volume of 814.77K. It is down -15.68% in the last 24 hours and down -22.20% over the past month. 22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
See More
Previous Close:
$1.55
Open:
$1.44
24h Volume:
814.77K
Relative Volume:
0.63
Market Cap:
$4.92M
Revenue:
$20.01M
Net Income/Loss:
$-14.40M
P/E Ratio:
-0.00262
EPS:
-500.5398
Net Cash Flow:
$-14.02M
1W Performance:
-13.44%
1M Performance:
-22.20%
6M Performance:
+30.05%
1Y Performance:
-90.80%
1-Day Range:
Value
$1.27
$1.49
1-Week Range:
Value
$1.27
$1.80
52-Week Range:
Value
$0.432
$17.13

22nd Century Group, Inc. Stock (XXII) Company Profile

Name
Name
22nd Century Group, Inc.
Name
Phone
716-270-1523
Name
Address
8560 Main Street, Williamsville, NY
Name
Employee
79
Name
Twitter
@_xxiicentury
Name
Next Earnings Date
2024-12-12
Name
Latest SEC Filings
Name
XXII's Discussions on Twitter

Compare XXII with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
XXII
22nd Century Group, Inc.
1.3005 5.86M 20.01M -14.40M -14.02M -500.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.80 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
627.73 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
422.21 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
836.09 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
183.03 39.72B 447.02M -1.18B -868.57M -6.1812

22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-21-22 Initiated Alliance Global Partners Buy
Jun-15-22 Initiated Craig Hallum Buy
Mar-08-22 Initiated ROTH Capital Buy
Jul-23-21 Initiated Cowen Outperform
Oct-16-17 Reiterated Chardan Capital Markets Buy
Aug-11-16 Reiterated Chardan Capital Markets Buy
View All

22nd Century Group, Inc. Stock (XXII) Latest News

pulisher
11:06 AM

22nd Century Group announces $25 million at-the-market equity program and executive agreements By Investing.com - Investing.com South Africa

11:06 AM
pulisher
09:56 AM

Earnings call transcript: 22nd Century’s Q3 2025 sees revenue dip, stock reacts - Investing.com

09:56 AM
pulisher
08:13 AM

How 22nd Century Group Inc. stock reacts to job market dataTrade Signal Summary & Daily Momentum Trading Reports - newser.com

08:13 AM
pulisher
07:41 AM

22nd Century Group Inc reports results for the quarter ended September 30Earnings Summary - TradingView

07:41 AM
pulisher
07:33 AM

22nd Century Group, Inc. SEC 10-Q Report - TradingView

07:33 AM
pulisher
06:58 AM

XXII Reports Q3 Revenue Amid Strategic Shift to Branded Products - GuruFocus

06:58 AM
pulisher
06:52 AM

22nd Century: Q3 Earnings Snapshot - San Francisco Chronicle

06:52 AM
pulisher
06:51 AM

22nd Century Group announces $25 million at-the-market equity program and executive agreements - Investing.com

06:51 AM
pulisher
06:40 AM

Is 22nd Century Group Inc. stock positioned for digital transformationSwing Trade & Daily Stock Momentum Reports - newser.com

06:40 AM
pulisher
06:39 AM

22nd Century Signs $25M Sales Agreement for Expansion - TipRanks

06:39 AM
pulisher
06:22 AM

22nd Century Group Cleans Up Finances But Misses Revenue Mark - Finimize

06:22 AM
pulisher
06:20 AM

22nd Century Group enters $25 million sales agreement with Needham & Company, LLCSEC filing - MarketScreener

06:20 AM
pulisher
06:16 AM

22nd Century Group Enters $25 Million Sales Agreement With Needham & Company, LLCSEC Filing - TradingView

06:16 AM
pulisher
06:03 AM

22nd Century Group Reports Third Quarter 2025 Financial Results - The Manila Times

06:03 AM
pulisher
06:00 AM

Alvotech (NASDAQ: ALVO) sets 10:45 am EDT fireside chat on Sept 10 with webcast - Stock Titan

06:00 AM
pulisher
05:15 AM

Developing predictive dashboards with 22nd Century Group Inc. dataQuarterly Profit Report & Safe Capital Preservation Plans - newser.com

05:15 AM
pulisher
03:13 AM

Is 22nd Century Group Inc. stock dividend yield sustainableJuly 2025 Breakouts & Weekly Watchlist of Top Performers - newser.com

03:13 AM
pulisher
01:06 AM

Can 22nd Century Group Inc. stock reach $100 price targetStop Loss & Low Drawdown Investment Strategies - newser.com

01:06 AM
pulisher
Nov 03, 2025

Will 22nd Century Group Inc. stock outperform Nasdaq indexJuly 2025 Spike Watch & High Yield Stock Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is 22nd Century Group Inc. stock a bargain at current levelsTrade Analysis Report & Daily Oversold Bounce Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using data filters to optimize entry into 22nd Century Group Inc.Quarterly Trade Report & Technical Pattern Recognition Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What MACD and RSI say about 22nd Century Group Inc.Share Buyback & Growth Focused Stock Pick Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can 22nd Century Group Inc. stock rebound after recent weaknessTrade Entry Summary & Stepwise Trade Execution Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How sentiment analysis helps forecast 22nd Century Group Inc.July 2025 Macro Moves & Weekly Consistent Profit Watchlists - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Can 22nd Century Group Inc. hit a new high this monthQuarterly Profit Review & Consistent Income Trade Ideas - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

How 22nd Century Group Inc. stock performs in rising dollar environmentJuly 2025 Market Mood & Safe Entry Point Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Applying Elliott Wave Theory to 22nd Century Group Inc.Weekly Trend Summary & Community Driven Trade Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

How to use a screener to detect 22nd Century Group Inc. breakoutsQuarterly Profit Review & Long Hold Capital Preservation Plans - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

22nd Century Group Inc (XXII) Stock Price | Live Quotes & Charts | NSC - StocksToTrade

Oct 31, 2025
pulisher
Oct 31, 2025

22nd Century Group Inc expected to post a loss of 73 cents a shareEarnings Preview - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

Is 22nd Century Group Inc. stock in correction or buying zoneJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can 22nd Century Group Inc. stock double in next 5 yearsTrade Exit Report & Safe Capital Growth Tips - newser.com

Oct 31, 2025

22nd Century Group, Inc. Stock (XXII) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.73
price up icon 1.14%
$28.86
price up icon 0.50%
$102.52
price up icon 0.94%
$104.56
price up icon 0.47%
biotechnology ONC
$310.20
price down icon 0.42%
$183.19
price down icon 1.64%
Cap:     |  Volume (24h):